Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HALOZYME THERAPEUTICS, INC. (HALO)
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Short-term debt | | | 13.3 | 99.0 | 89.5 | 89.4 | 89.3 | 89.2 |
| Long-term debt | 1,496.0 | 1,494.4 | 1,491.2 | 2,025.7 | 1,665.7 | 1,663.9 | 1,662.2 | 1,660.3 |
| Total debt | 1,496.0 | 1,494.4 | 1,504.5 | 2,124.8 | 1,755.3 | 1,753.3 | 1,751.4 | 1,749.5 |
| Net debt | 1,274.8 | 1,218.8 | 1,238.9 | 1,915.4 | 969.2 | 1,012.4 | 935.5 | 994.2 |
| |
| Debt to EBITDA | | | 5.1 | 8.3 | 5.8 | 6.3 | 5.8 | 6.6 |
| Net debt to EBITDA | | | 4.2 | 7.5 | 3.2 | 3.6 | 3.1 | 3.8 |
| |
| EBITDA interest coverage | | | 20.3 | 29.6 | 41.5 | 37.1 | 28.6 | 19.3 |
| EBIT interest coverage | | | 17.3 | 27.9 | 41.1 | 36.7 | 28.3 | 19.0 |
|